Teleflex Incorporated (TFX) Holdings Trimmed by DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale lowered its stake in shares of Teleflex Incorporated (NYSE:TFX) by 11.7% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,998 shares of the medical technology company’s stock after selling 398 shares during the period. DekaBank Deutsche Girozentrale’s holdings in Teleflex were worth $821,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Aristotle Atlantic Partners LLC purchased a new position in Teleflex during the fourth quarter worth approximately $202,000. Dean Capital Investments Management LLC purchased a new position in Teleflex during the first quarter worth approximately $230,000. Quantitative Systematic Strategies LLC purchased a new position in Teleflex during the fourth quarter worth approximately $228,000. Checchi Capital Advisers LLC purchased a new position in Teleflex during the fourth quarter worth approximately $230,000. Finally, Lourd Capital LLC purchased a new position in Teleflex during the fourth quarter worth approximately $266,000. 88.96% of the stock is currently owned by institutional investors.

A number of equities analysts have weighed in on TFX shares. Leerink Swann reaffirmed a “buy” rating and set a $321.00 price target (up previously from $307.00) on shares of Teleflex in a research note on Tuesday, January 30th. Needham & Company LLC increased their price target on shares of Teleflex from $293.00 to $298.00 and gave the stock a “buy” rating in a research note on Tuesday, May 15th. TheStreet downgraded shares of Teleflex from an “a-” rating to a “c+” rating in a research note on Monday, March 12th. Deutsche Bank set a $255.00 price objective on shares of Teleflex and gave the stock a “hold” rating in a research report on Friday, May 4th. Finally, ValuEngine lowered shares of Teleflex from a “buy” rating to a “hold” rating in a research report on Wednesday, March 7th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and six have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $280.80.

In related news, Director George Babich, Jr. sold 2,500 shares of the firm’s stock in a transaction on Monday, March 12th. The shares were sold at an average price of $268.53, for a total transaction of $671,325.00. Following the completion of the sale, the director now directly owns 11,083 shares of the company’s stock, valued at approximately $2,976,117.99. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP John Deren sold 1,359 shares of the firm’s stock in a transaction on Wednesday, February 28th. The shares were sold at an average price of $255.67, for a total transaction of $347,455.53. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 41,852 shares of company stock valued at $10,912,697. Company insiders own 2.56% of the company’s stock.

Teleflex opened at $264.35 on Friday, MarketBeat.com reports. Teleflex Incorporated has a 52-week low of $193.50 and a 52-week high of $288.78. The firm has a market capitalization of $11.82 billion, a PE ratio of 31.47, a price-to-earnings-growth ratio of 1.82 and a beta of 1.19. The company has a quick ratio of 1.45, a current ratio of 2.18 and a debt-to-equity ratio of 0.84.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, May 3rd. The medical technology company reported $2.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.94 by $0.21. Teleflex had a net margin of 7.51% and a return on equity of 16.60%. The company had revenue of $587.23 million during the quarter, compared to analyst estimates of $568.29 million. During the same quarter in the prior year, the business earned $1.80 earnings per share. The business’s quarterly revenue was up 20.4% compared to the same quarter last year. research analysts anticipate that Teleflex Incorporated will post 9.83 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, June 15th. Investors of record on Tuesday, May 15th will be issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 0.51%. The ex-dividend date of this dividend is Monday, May 14th. Teleflex’s payout ratio is 16.19%.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease.

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.




Leave a Reply